Dr. Jingyin Yan, MD, PhD

Dr. Yan practices at US Renal Care Sharpstown Dialysis in Houston, Texas.

Dr. Yan's NPI, 1982865721, was assigned on June 24, 2008. Dr. Yan graduated from Shanghai Jiao Tong University School of Medicine in 2002. Dr. Yan's Texas license number on file is P4919.

Dr. Yan's primary practice is US Renal Care Sharpstown Dialysis, at 2 Greenway Plz, Houston, TX 77046 in Harris County. The practice phone is (713) 481-8929.

Dr. Yan's primary practice is US Renal Care Sharpstown Dialysis in Houston, Texas. Dr. Yan is also affiliated with Harris Health Ben Taub Hospital. The medical group on file is Baylor Medicine. Dmand AI also links Dr. Yan to 1 more hospital, 5 dialysis centers, 3 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Yan practices, 10 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Yan's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Yan is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Yan's licenses on file in 2 states: Texas and Nevada.

Dmand AI lists acute kidney failure, chronic anemia, chronic kidney disease, fluid and electrolyte imbalances, hypercalcemia, kidney cysts and kidney disease among the conditions Dr. Yan treats.

CMS data shows 851 Medicare services from Dr. Yan across 12 procedure codes in 2024, for 211 Medicare patients. Medicare paid $110,247 for them.

CMS counts 211 Medicare patients who saw Dr. Yan in 2024. The largest group is 65 to 74, with 74 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 27% are also on Medicaid. Their average risk score is 4.28, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Yan's median patient age at 60, with 46% women.

In 2024, Dr. Yan wrote 730 Medicare Part D claims for 142 patients. 79% of them were for generic drugs. CMS names the drug for 517 of them, across 21 drugs with 11 or more claims each, at $195,751 in total drug cost.

Dr. Yan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Yan as offering telehealth.

Dmand AI links 16 papers to Dr. Yan, published from 2012 to 2023. 2014 was the busiest year, with 3. The most frequent topics are Renal Dialysis, Renal Insufficiency, Chronic and Chemokine CXCL6. Dr. Yan has published most often in Am J Kidney Dis. Dr. Yan's most frequent co-authors are Sankar Dass Navaneethan, MD, Yanlin Wang, MD and Wolfgang C. Winkelmayer, DSC, MD.

Dmand AI links Dr. Yan to 2 clinical trials, 2 of them phase 4 studies. 1 is still active or recruiting. Conditions studied include Glomerulonephritis, IGA, Kidney Failure, Chronic and Proteinuria.

CMS Open Payments shows 28 general payments to Dr. Yan from 6 drug and device companies from 2024 to 2025. Consulting fees make up the largest share, 83% of the total. Otsuka America Pharmaceutical, Inc. paid the most, $7,197.

Dr. Yan graduated from Shanghai Jiao Tong University School of Medicine in 2002.

Dr. Yan is in network with 19 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.